7-Hydroxy-6-methoxy-2-methylspiro[3,4-dihydroisoquinoline-1,7'-[1,3]dioxolo[4,5-h]isochromene]-6',9'-dione

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 四氢异喹啉
• 英文名称: 7-Hydroxy-6-methoxy-2-methylspiro[3,4-dihydroisoquinoline-1,7'-[1,3]dioxolo[4,5-h]isochromene]-6',9'-dione
• 化学式: C₂₀H₁₇NO₇
• 分子量: 383.4
• InChiKey: KGKOOVYBLRJXFR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  28
• 可旋转键数：
  1
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  94.5
• 氢给体数：
  1
• 氢受体数：
  8

文献信息

• COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF INFLAMMATORY DISORDERS
  申请人：DSM IP Assets B.V.

  公开号：EP2040696A2

  公开（公告）日：2009-04-01
• COMPOSITIONS COMPRISING ROSEHIP AND OTHER ACTIVE AGENTS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
  申请人：DSM IP Assets B.V.

  公开号：EP2049134A2

  公开（公告）日：2009-04-22
• Topical Composition And Method Of Forming
  申请人：Grigsby Charles

  公开号：US20080138417A1

  公开（公告）日：2008-06-12

  The present invention provides a topical composition for use in treating medical conditions such as fungal epithelial infections, carpal tunnel syndrome, tendonitis, and arthritis. The topical composition includes a mineral component including a source of calcium and a source of potassium, a vitamin component including a source of ascorbic acid, and an anti-inflammatory component including a source of lysine and a source of glutathione. The topical composition also includes an anti-oxidant component including a source of curcumin and an isoflavone component including a source of ipriflavone. The present invention also provides a method of forming the topical composition. The method includes combining the mineral component, the vitamin component, the anti-inflammatory component, the anti-oxidant component, and the isoflavone component.
• NOVEL COMPOSITIONS
  申请人：Raederstorff Daniel

  公开号：US20100055218A1

  公开（公告）日：2010-03-04

  The present invention relates to novel compositions comprising rosehip and at least one additional component e.g. selected from ligustilide, oleuropein (I), oleuropein aglycone (II), hydroxytyrosol, genistein, magnolol, honokiol, magnolia bark extract, cashew fruit extract and Glycyrrhiza foetida as well as to the use of these compositions as a medicament, in particular as a medicament for the treatment, co-treatment or prevention of inflammatory disorders.
• US8841264B2
  申请人：——

  公开号：US8841264B2

  公开（公告）日：2014-09-23